From Covid to cancer: High hopes for 'versatile' mRNA

13 Sept 07:57 Key points summarised by AI

mRNA technology, widely recognized from COVID-19 vaccines, represents a versatile medical platform with decades of research into diverse applications beyond infectious diseases.
This revolutionary technology works by directly instructing human cells to produce specific antigens, effectively training the immune system to combat viruses or illnesses.
Pivotal research, notably the 2005 discovery of lipid envelopes, overcame initial challenges of immune rejection and mRNA fragility, enabling its safe and effective delivery within the body.
Beyond its use in vaccines for infectious diseases like flu and malaria, mRNA is now being developed for personalized cancer therapies, activating the immune system to target specific tumor cells.

Uthenthawai students and alumni declare truce with Pathumwan rivals

Yesterday 20:34 Key points summarised by AI

Uthenthawai students and alumni have pledged to cease violent clashes with Pathumwan Institute rivals, coinciding with their campus's reopening after a 90-day closure.
The Minister of Higher Education is mediating the long-running conflict, while the campus closure has significantly disrupted in-person classes and laboratory work for over 1,000 students.
Uthenthawai resists relocation from its current site, citing a historical land grant from King Rama VI, despite Chulalongkorn University's plans to reclaim the land for an educational hub.
Concerns are mounting over the legality of the campus closure, its detrimental impact on uninvolved students, and the potential commercial development of the land, which critics argue contradicts the late King Rama VI's intentions.